Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings

Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings

Show other versions (1)

<h4>Introduction</h4> Despite the rising burden of chronic respiratory disease globally, and although many respiratory medications are included in the World Health Organization Essential Medications List (WHO-EML), there is limited information concerning the availability and affordabilit...

Full description

Bibliographic Details
Main Authors: Trishul Siddharthan, Nicole M. Robertson, Natalie A. Rykiel, Lindsay J. Underhill, Nihaal Rahman, Sujan Kafle, Sakshi Mohan, Roma Padalkar, Sarah McKeown, Oscar Flores-Flores, Shumonta A. Quaderi, Patricia Alupo, Robert Kalyesubula, Bruce Kirenga, Jing Luo, Maria Kathia Cárdenas, Gonzalo Gianella, J. Jaime Miranda, William Checkley, John R. Hurst, Suzanne L. Pollard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLOS Global Public Health
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021856/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021856/?tool=EBI

Similar Items